Slow Coagulation Transscleral Cyclophotocoagulation for Post
Slow coagulation transscleral cyclophotocoagulation is an effective and safe glaucoma surgery in patients with medically uncontrolled silicone oil-induced glaucoma.

A Study was conducted to report the outcomes of slow coagulation continuous wave transscleral cyclophotocoagulation (CW-TSCPC) in patients with medically uncontrolled secondary glaucoma following pars plana vitrectomy (PPV) and intravitreal silicone oil injection (SOI).

This retrospective study enrolled patients with medically uncontrolled glaucoma secondary to PPV with SOI who underwent TSCPC using slow coagulation TSCPC settings. The primary outcome measure was surgical success at 12 months. Surgical success was defined as an IOP 6-21mmHg and reduced more than 20% from baseline, no reoperation for glaucoma, and no loss of light-perception vision. Secondary outcome measures included number of glaucoma medications, visual acuity (VA) changes, and surgical complications.

--A total of 18 eyes of 18 patients were included in the study. The mean age and follow up of the patients were 51.94±14.5 years and 16.3±3.5 months, respectively.

--The mean IOP decreased from 29.7±9.6mmHg preoperatively to 14.6±6.5mmHg at 12 months postoperatively.

--Glaucoma medications were reduced from 4.2±0.9 at baseline to 1.9±1.3 at 12 months after TSCPC.

--A non-significant change of logMAR VA was observed at 12 months. The success rate at 12 months was 72.2%. No major complications were reported during the first year of follow-up.

In conclusion, the slow coagulation TSCPC is highly effective and has minimal problems in patients with SO-induced glaucoma when utilized as the initial glaucoma surgic operation.